194 related articles for article (PubMed ID: 32451712)
1. Fifteen years of newborn sickle cell disease screening in Madrid, Spain: an emerging disease in a European country.
García-Morín M; Bardón-Cancho EJ; Beléndez C; Zamarro R; Béliz-Mendiola C; González-Rivera M; Vecilla C; Llorente-Otones L; Pérez-Alonso V; Román SS; Sebastián E; Dulín E; Cela E
Ann Hematol; 2020 Jul; 99(7):1465-1474. PubMed ID: 32451712
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
[TBL] [Abstract][Full Text] [Related]
3. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
[TBL] [Abstract][Full Text] [Related]
4. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
[TBL] [Abstract][Full Text] [Related]
5. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
[TBL] [Abstract][Full Text] [Related]
7. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction].
Cela de Julián E; Dulín Iñiguez E; Guerrero Soler M; Arranz Leirado M; Galarón García P; Beléndez Bieler C; Bellón Cano JM; García Arias M; Cantalejo López A
An Pediatr (Barc); 2007 Apr; 66(4):382-6. PubMed ID: 17430715
[TBL] [Abstract][Full Text] [Related]
9. [Newborn screening for sickle cell disease in France].
Brousse V; Allaf B; Benkerrou M
Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
[TBL] [Abstract][Full Text] [Related]
10. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
11. Neonatal haemoglobinopathy screening in Spain.
Mañú Pereira M; Corrons JL
J Clin Pathol; 2009 Jan; 62(1):22-5. PubMed ID: 19103853
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole EO; Adeyemo TA; Osanyin GE; Odukoya OO; Kanki PJ; Afolabi BB
PLoS One; 2020; 15(12):e0242861. PubMed ID: 33270733
[TBL] [Abstract][Full Text] [Related]
15. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
16. A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.
McGann PT; Grosse SD; Santos B; de Oliveira V; Bernardino L; Kassebaum NJ; Ware RE; Airewele GE
J Pediatr; 2015 Dec; 167(6):1314-9. PubMed ID: 26477868
[TBL] [Abstract][Full Text] [Related]
17. Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
García-Morin M; Bardón-Cancho EJ; Beléndez C; Dulín E; Blanco-Soto P; Puertas-López C; Prieto-Medina M; Cervera-Bravo Á; Llorente-Otones L; Pérez-Alonso V; San-Román S; Vecilla-Rivelles C; López-Rubio M; Sebastián E; Bellón JM; Cela E
Ann Hematol; 2024 Feb; 103(2):373-383. PubMed ID: 37980280
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
Dexter D; McGann PT
Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
Lobitz S; Telfer P; Cela E; Allaf B; Angastiniotis M; Backman Johansson C; Badens C; Bento C; Bouva MJ; Canatan D; Charlton M; Coppinger C; Daniel Y; de Montalembert M; Ducoroy P; Dulin E; Fingerhut R; Frömmel C; García-Morin M; Gulbis B; Holtkamp U; Inusa B; James J; Kleanthous M; Klein J; Kunz JB; Langabeer L; Lapouméroulie C; Marcao A; Marín Soria JL; McMahon C; Ohene-Frempong K; Périni JM; Piel FB; Russo G; Sainati L; Schmugge M; Streetly A; Tshilolo L; Turner C; Venturelli D; Vilarinho L; Yahyaoui R; Elion J; Colombatti R;
Br J Haematol; 2018 Nov; 183(4):648-660. PubMed ID: 30334577
[TBL] [Abstract][Full Text] [Related]
20. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
